NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number
NO20090027L
NO20090027L NO20090027A NO20090027A NO20090027L NO 20090027 L NO20090027 L NO 20090027L NO 20090027 A NO20090027 A NO 20090027A NO 20090027 A NO20090027 A NO 20090027A NO 20090027 L NO20090027 L NO 20090027L
Authority
NO
Norway
Prior art keywords
vasoactive intestinal
intestinal peptide
new analog
analog
new
Prior art date
Application number
NO20090027A
Other languages
English (en)
Norwegian (no)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57563Vasoactive intestinal peptide [VIP]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06
PCT/EP2007/056351 WO2008003612A2 (en) 2006-07-06 2007-06-26 Analogs of vasoactive intestinal peptide

Publications (1)

Publication Number Publication Date
NO20090027L true NO20090027L (no) 2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090027A NO20090027L (no) 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country Link
US (1) US20080096807A1 (ja)
EP (1) EP2041168A2 (ja)
JP (1) JP2009542593A (ja)
KR (1) KR20090027239A (ja)
CN (1) CN101484468A (ja)
AR (1) AR061825A1 (ja)
AU (1) AU2007271274A1 (ja)
BR (1) BRPI0714306A2 (ja)
CA (1) CA2656757A1 (ja)
CL (1) CL2007001956A1 (ja)
CR (1) CR10518A (ja)
EC (1) ECSP099029A (ja)
IL (1) IL196122A0 (ja)
MA (1) MA30590B1 (ja)
MX (1) MX2009000013A (ja)
NO (1) NO20090027L (ja)
PE (1) PE20081000A1 (ja)
RU (1) RU2009103811A (ja)
TW (1) TW200819139A (ja)
WO (1) WO2008003612A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012151296A (ru) 2010-04-30 2014-06-10 Санва Кагаку Кенкюсо Ко., Лтд Пептид для улучшения биостабильности биоактивного вещества и биоактивное вещество, имеющее повышенную биостабильность
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
US9789164B2 (en) * 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
US11052132B2 (en) * 2014-05-08 2021-07-06 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
AU722895B2 (en) * 1996-02-09 2000-08-10 F. Hoffmann-La Roche Ag Synthesis of VIP analog
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
WO2006023358A1 (en) * 2004-08-18 2006-03-02 Eli Lilly And Company Selective vpac2 receptor peptide agonists
MX2007004116A (es) * 2004-10-08 2007-10-05 Forbes Medi Tech Res Inc Composiciones farmaceuticas de polipeptidos intestinales vasoactivos.

Also Published As

Publication number Publication date
EP2041168A2 (en) 2009-04-01
IL196122A0 (en) 2011-08-01
AU2007271274A1 (en) 2008-01-10
PE20081000A1 (es) 2008-08-06
AR061825A1 (es) 2008-09-24
MX2009000013A (es) 2009-01-23
CN101484468A (zh) 2009-07-15
BRPI0714306A2 (pt) 2014-05-20
KR20090027239A (ko) 2009-03-16
WO2008003612A3 (en) 2008-02-28
US20080096807A1 (en) 2008-04-24
RU2009103811A (ru) 2010-08-20
MA30590B1 (fr) 2009-07-01
CA2656757A1 (en) 2008-01-10
TW200819139A (en) 2008-05-01
WO2008003612A2 (en) 2008-01-10
CL2007001956A1 (es) 2008-04-18
JP2009542593A (ja) 2009-12-03
ECSP099029A (es) 2009-02-27
CR10518A (es) 2009-01-27

Similar Documents

Publication Publication Date Title
NO20090027L (no) Ny analog av vasoaktivt tarmpeptid
MX2009012967A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
MX2009012968A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
DK1718336T3 (da) Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme
WO2008149144A3 (en) Polypeptides, antibody variable domains and antagonists
MX2009013990A (es) Metodos para tratar enfermedades y trastornos mediados por serotonina.
WO2006117299A3 (en) Novel crystalline forms of tiotropium bromide
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
WO2008082613A3 (en) Factor ix moiety-polymer conjugates having a releasable linkage
TW200738632A (en) Cannabinoid receptor modulators
WO2007076260A3 (en) Farnesoid x receptor agonists
WO2008070111A3 (en) Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2004050610A3 (en) Modulators of melanocortin receptor
WO2010149578A3 (en) Novel biphenyl and phenyl-pyridine amides
MX2011008799A (es) Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
EP3087988A3 (en) Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
MX2009001534A (es) Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
WO2010048477A3 (en) Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
MX2009013829A (es) Composiciones terapeuticas y su uso.
UA90706C2 (ru) Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
WO2007079163A3 (en) Prokineticin 1 receptor antagonists
TW200630336A (en) Novel compounds
NO20081428L (no) Tetrahydrokinolinoner og anvendelse derav som modulatorer av metabotrope glutamatreseptorer
NO20091741L (no) Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
MX2009007911A (es) Inhibidores de proteina tirosina fosfatasa 1b aromaticos fusionados.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application